Peroxisome proliferator-activated receptor gamma in diabetes and metabolism
about
Adipocyte NCoR knockout decreases PPARγ phosphorylation and enhances PPARγ activity and insulin sensitivityExpression of PPARdelta in multistage carcinogenesis of the colorectum: implications of malignant cancer morphologyMechanisms of Muscle Denervation in Aging: Insights from a Mouse Model of Amyotrophic Lateral SclerosisPPAR-γ -- a possible drug target for complicated pregnanciesAlzheimer Disease: Crosstalk between the Canonical Wnt/Beta-Catenin Pathway and PPARs Alpha and GammaAnti-Inflammatory Effects of Rosiglitazone in Obesity-Impaired Wound Healing Depend on Adipocyte DifferentiationMolecular, biochemical and functional characterizations of C1q/TNF family members: adipose-tissue-selective expression patterns, regulation by PPAR-gamma agonist, cysteine-mediated oligomerizations, combinatorial associations and metabolic functionsEffect of pioglitazone on in-stent restenosis after coronary drug-eluting stent implantation: a meta-analysis of randomized controlled trialsRole of the BAHD1 Chromatin-Repressive Complex in Placental Development and Regulation of Steroid MetabolismGenome-wide profiling of H3K56 acetylation and transcription factor binding sites in human adipocytesAdiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndromeDipeptidyl peptidase IV inhibitor lowers PPARγ agonist-induced body weight gain by affecting food intake, fat mass, and beige/brown fat but not fluid retentionCytotoxicity of 15-deoxy-Δ(12,14)-prostaglandin J(2) through PPARγ-independent pathway and the involvement of the JNK and Akt pathway in renal cell carcinoma.De-novo identification of PPARgamma/RXR binding sites and direct targets during adipogenesis.The peroxisome proliferator-activated receptor-alpha (PPAR-alpha) agonist, AVE8134, attenuates the progression of heart failure and increases survival in rats.Tumor grade related expression of neuroglobin is negatively regulated by PPARγ and confers antioxidant activity in glioma progressionAnti-diabetic rosiglitazone remodels the adipocyte transcriptome by redistributing transcription to PPARγ-driven enhancers.PPARG and ADIPOQ gene polymorphisms increase type 2 diabetes mellitus risk in Asian Indian Sikhs: Pro12Ala still remains as the strongest predictor.Thermodynamics in Gliomas: Interactions between the Canonical WNT/Beta-Catenin Pathway and PPAR GammaType 2 Diabetes Mellitus and Cancer: The Role of Pharmacotherapy.Multiple roles for the non-coding RNA SRA in regulation of adipogenesis and insulin sensitivity.Specific thiazolidinediones inhibit ovarian cancer cell line proliferation and cause cell cycle arrest in a PPARγ independent manner.Cannabinoids go nuclear: evidence for activation of peroxisome proliferator-activated receptors.Peroxisome proliferator-activated receptor gamma activation inhibits progesterone-stimulated human MUC1 expression.Peroxisome proliferator-activated receptors for hypertension.Pioglitazone modulates the proliferation and apoptosis of vascular smooth muscle cells via peroxisome proliferators-activated receptor-gamma.Targeting steroid receptor coactivator 1 with antisense oligonucleotides increases insulin-stimulated skeletal muscle glucose uptake in chow-fed and high-fat-fed male ratsGenetic polymorphisms of the main transcription factors for adiponectin gene promoter in regulation of adiponectin levels: association analysis in three European cohorts.Revisiting PPARγ as a target for the treatment of metabolic disordersIncreasing adipocyte lipoprotein lipase improves glucose metabolism in high fat diet-induced obesityPeroxisome proliferator-activated receptors, metabolic syndrome and cardiovascular disease.The Genetic Basis of the Polycystic Ovary Syndrome: A Literature Review Including Discussion of PPAR-gamma.Activation of peroxisome proliferator-activated receptor gamma contributes to the survival of T lymphoma cells by affecting cellular metabolism.The orphan nuclear receptor small heterodimer partner is required for thiazolidinedione effects in leptin-deficient mice.Obesity and Diabetes: The Increased Risk of Cancer and Cancer-Related Mortality.Cardiomyocyte expression of PPARgamma leads to cardiac dysfunction in mice.Insulin sensitivity improvement of fermented Korean Red Ginseng (Panax ginseng) mediated by insulin resistance hallmarks in old-aged ob/ob micePPAR-gamma in the Cardiovascular SystemProminent role of exopeptidase DPP III in estrogen-mediated protection against hyperoxia in vivoPeroxisome Proliferators-Activated Receptor (PPAR) Modulators and Metabolic Disorders.
P2860
Q24296924-9B50AF8E-84E4-48E2-AF44-3C8E5E2598C6Q24652863-6564A666-F3C8-45FD-8617-6F96DFFB31C7Q26783337-D17DE022-DDB7-42DB-AEB5-5A6CE3421294Q26863678-2BB16732-A733-4593-99A0-09EC2BF39FCEQ28075617-01255595-F925-4CEA-ACCD-B85AA32133F1Q28354076-4B070E00-62F6-4353-9BB5-F5BC73B5941EQ28508387-77785EE1-6822-4579-BD3B-0484832EA2D1Q28543544-E99C9B1F-D041-41F9-9B7F-7863607A7E33Q28550503-F911A71B-FAA7-4EA2-91BE-C0D45429030FQ28744034-58D0857F-D3AA-42B9-ABF2-FF84F509B5ECQ29619211-E820EB80-7CC2-4292-BF60-049A111336BEQ30717371-B2A45213-6B5C-4AE7-9C94-BBCCBD96684BQ31093216-7EDD52FD-62AB-4721-86FA-EB6878389EE1Q33419872-CF1ECCB6-C513-4B35-AC5C-B785EA218BAAQ33552642-C7DC5A99-A810-43E7-8764-8C24DA3B2515Q33561578-93B28189-D66B-4C63-B5E3-7C77706F14B6Q33600223-4A2DDDC7-1A28-4DC7-B955-B31772E8AE94Q33746525-2A8A2F75-0E9F-43EB-BFAA-462A9D361ECCQ33748280-534ABF9A-0F28-4C37-B722-E463BC1D82DEQ33756414-85F1FA90-9C98-4B0E-BBF6-6F7C61EA7132Q33769840-6BA75D87-C9D9-418E-899E-224CE49420D9Q33809071-430812DA-240F-4A58-9F7D-E0FF27BFE3A5Q33845285-17DE9BD1-41A8-4B34-8FA9-3308270BAC0DQ33993702-C0A9DC23-A386-4C88-95B3-23670F93B0ACQ34179017-22C25FFD-F61D-4A5B-8058-0DE45AA5210AQ34309135-4A7E7AC0-C882-45F0-AD57-13BB8DBE77CBQ34439547-55CB2870-DC3F-48A5-8890-98EDF7E6742FQ34534005-2ABA85D3-6051-42DC-B6D3-5B662FE26ABBQ34798213-B3C59E6B-D493-4AC8-925C-91A45F550248Q35561055-CB6BA978-1CCD-44F4-9EE7-A28E3BC5AC3DQ35636191-7F5E6794-DF8E-42AC-8D8A-D7BD02E1BABEQ35676497-DB6F7FB0-108D-43B9-8461-D8E66C872F38Q35750111-4C1DDA04-48AE-4F26-8FF9-65A8DAB703EDQ35810498-A060D110-4B54-4C5A-BBAC-79C7623F2C07Q35817986-FE2A6270-2D84-4A1A-8075-0B1731935311Q35970883-8956619F-6802-4D73-918C-5ACC17B20C63Q36122665-AE0AF621-09B0-4A3B-8C01-C3ED93E54E97Q36426786-0EE81D57-D4B1-48DD-BAB2-D5F8FD669576Q36517731-81F30E03-10A4-4AAD-9831-8D005528038EQ36724770-45D1A83E-ABAD-4764-B57C-B79F9D5942B8
P2860
Peroxisome proliferator-activated receptor gamma in diabetes and metabolism
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Peroxisome proliferator-activated receptor gamma in diabetes and metabolism
@ast
Peroxisome proliferator-activated receptor gamma in diabetes and metabolism
@en
Peroxisome proliferator-activated receptor gamma in diabetes and metabolism
@nl
type
label
Peroxisome proliferator-activated receptor gamma in diabetes and metabolism
@ast
Peroxisome proliferator-activated receptor gamma in diabetes and metabolism
@en
Peroxisome proliferator-activated receptor gamma in diabetes and metabolism
@nl
prefLabel
Peroxisome proliferator-activated receptor gamma in diabetes and metabolism
@ast
Peroxisome proliferator-activated receptor gamma in diabetes and metabolism
@en
Peroxisome proliferator-activated receptor gamma in diabetes and metabolism
@nl
P1476
Peroxisome proliferator-activated receptor gamma in diabetes and metabolism
@en
P2093
Mitchell A Lazar
Shamina M Rangwala
P356
10.1016/S0165-6147(04)00115-4
P407
P577
2004-06-01T00:00:00Z